These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10693992)

  • 1. Superantigens, conventional antigens and the etiology of Kawasaki syndrome.
    Meissner HC; Leung DY
    Pediatr Infect Dis J; 2000 Feb; 19(2):91-4. PubMed ID: 10693992
    [No Abstract]   [Full Text] [Related]  

  • 2. The potential role of bacterial superantigens in the pathogenesis of Kawasaki syndrome.
    Leung DY; Meissner C; Fulton D; Schlievert PM
    J Clin Immunol; 1995 Nov; 15(6 Suppl):11S-17S. PubMed ID: 8613483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for the involvement of bacterial superantigens in psoriasis, atopic dermatitis, and Kawasaki syndrome.
    Yarwood JM; Leung DY; Schlievert PM
    FEMS Microbiol Lett; 2000 Nov; 192(1):1-7. PubMed ID: 11040420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of serum IgM antibodies against superantigens of Staphylococcus aureus and Streptococcus pyogenes in Kawasaki disease.
    Matsubara K; Fukaya T; Miwa K; Shibayama N; Nigami H; Harigaya H; Nozaki H; Hirata T; Baba K; Suzuki T; Ishiguro A
    Clin Exp Immunol; 2006 Mar; 143(3):427-34. PubMed ID: 16487241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serologic evidence that streptococcal superantigens are not involved in the pathogenesis of Kawasaki disease.
    Morita A; Imada Y; Igarashi H; Yutsudo T
    Microbiol Immunol; 1997; 41(11):895-900. PubMed ID: 9444333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of guttate psoriasis following Kawasaki disease.
    Han MH; Jang KA; Sung KJ; Moon KC; Koh JK; Choi JH
    Br J Dermatol; 2000 Mar; 142(3):548-50. PubMed ID: 10735970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Reaction to cytarabine (Ara-C) treatment in patients with concurrent Staphylococcus aureus infection: a coalition between Ara-C and superantigens?".
    Savaşan S; Warrier I; Can E; Can M; Gedikoğlu G
    Med Pediatr Oncol; 1998 Apr; 30(4):263-4. PubMed ID: 9473764
    [No Abstract]   [Full Text] [Related]  

  • 8. Superantigens in the aetiology of Kawasaki disease.
    Fischer P; Uttenreuther-Fischer MM; Gaedicke G
    Lancet; 1996 Jul; 348(9021):202. PubMed ID: 8684184
    [No Abstract]   [Full Text] [Related]  

  • 9. Kawasaki disease and toxic shock syndrome--at last the etiology is clear?
    Curtis N
    Adv Exp Med Biol; 2004; 549():191-200. PubMed ID: 15250533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superantigens and Kawasaki disease.
    Furukawa S; Matsubara T; Yabuta K
    Immunol Today; 1991 Dec; 12(12):464. PubMed ID: 1786081
    [No Abstract]   [Full Text] [Related]  

  • 11. Superantigens related to Kawasaki syndrome.
    Leung DY
    Springer Semin Immunopathol; 1996; 17(4):385-96. PubMed ID: 8966663
    [No Abstract]   [Full Text] [Related]  

  • 12. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome.
    Nishiyori A; Sakaguchi M; Kato H; Igarashi H; Miwa K
    Lancet; 1994 Jan; 343(8892):299-300. PubMed ID: 7905128
    [No Abstract]   [Full Text] [Related]  

  • 13. Superantigens in Kawasaki syndrome.
    Leung DY; Meissner HC; Fulton DR; Quimby F; Schlievert PM
    Clin Immunol Immunopathol; 1995 Nov; 77(2):119-26. PubMed ID: 7586718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum anti-Yersinia antibody in Chinese patients with Kawasaki disease.
    Chou CT; Chang JS; Ooi SE; Huo AP; Chang SJ; Chang HN; Tsai CY
    Arch Med Res; 2005; 36(1):14-8. PubMed ID: 15777989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease.
    Leung DY; Meissner HC; Shulman ST; Mason WH; Gerber MA; Glode MP; Myones BL; Wheeler JG; Ruthazer R; Schlievert PM
    J Pediatr; 2002 Jun; 140(6):742-6. PubMed ID: 12072880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of superantigens of group A Streptococcus and Staphylococcus aureus in Kawasaki disease.
    Matsubara K; Fukaya T
    Curr Opin Infect Dis; 2007 Jun; 20(3):298-303. PubMed ID: 17471041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of bacterial superantigens to atopic dermatitis.
    Herz U; Bunikowski R; Mielke M; Renz H
    Int Arch Allergy Immunol; 1999; 118(2-4):240-1. PubMed ID: 10224396
    [No Abstract]   [Full Text] [Related]  

  • 18. Superantigens in dermatology.
    Macias ES; Pereira FA; Rietkerk W; Safai B
    J Am Acad Dermatol; 2011 Mar; 64(3):455-72; quiz 473-4. PubMed ID: 21315950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome.
    Curtis N; Chan B; Levin M
    Lancet; 1994 Jan; 343(8892):299. PubMed ID: 7905127
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytopathogenic protein (CPP) produced by Propionibacterium acnes isolated from patients with Kawasaki disease.
    Tomita S; Koga Y; Inoue O; Fujimoto T; Kato H
    Prog Clin Biol Res; 1987; 250():73-80. PubMed ID: 3423083
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.